1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow EDP167: new trials by email Literature Review of EDP167 trials Research Report on EDP167
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-exploration Study of EDP167 in HoFH EDP167 - Homozygous Familial Hypercholesterolemia (HoFH) | Phase 2 | Recruiting | Eddingpharm (Zhuhai) Co., Ltd. | 20 | 2026-02-06 | 2026-05-20 |
| EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia EDP167, Placebo - Healthy Adult Male and Female Volunteers, Mild Dyslipidemia | Phase 1 | Completed | Eddingpharm (Zhuhai) Co., Ltd. | 40 | 2025-07-01 | 2026-02-17 |
Dyslipidemias (2) · Homozygous Familial Hypercholesterolemia (1)
Eddingpharm (Zhuhai) Co., Ltd. (2)
China (2)
Kefei Dou, MD (1)